New Delhi: 20th October 2011
An experimental vaccine from GlaxoSmithKline halved the risk of African children getting malaria in a major clinical trial, making it likely to become the world’s first shot against the disease. Read More
0 Comments
Leave a Reply. |
Health News Update
Archives
December 2013
Categories |